The authors concluded that the technical success and subsequent durability of percutaneous transluminal angioplasty was limited compared with bypass surgery. Limb salvage was comparable between the two surgical methods. Methodological limitations of the review and a lack of studies that compared the two methods directly meant that the conclusions may not be reliable.
Study selection
Studies that evaluated middle term outcomes (such as immediate technical success, primary and secondary patency, limb salvage and patient survival) after infra-popliteal angioplasty in patients with chronic critical limb ischemia were included in the review. Studies had to assess a minimum of 15 crural percutaneous transluminal angioplasties. Most patients had to have ischemic rest pain or tissue loss. Inclusion criteria regarding study designs were not defined, although studies had to present survival analysis and have a minimum follow up of 12 months. Studies lacking demographic data or information on clinical variables were not excluded. Studies were excluded if they did not describe a greater number of percutaneous transluminal angioplasties when results were reported together with formocresol percutaneous transluminal angioplasties.
The mean age of the participants ranged from 64 to 81 years. Most of the included studies targeted patients with critical limb ischemia: two studies targeted diabetic participants; two targeted participants with end-stage renal disease; and two targeted poor candidates for bypass. Most of the included studies used a retrospective design.
